Montelukast, an asthma drug, can bind to and block a crucial SARS-CoV-2 protein. This discovery sets the stage for a new class of antiviral drugs, designed to target and interfere with the virus' immunosuppressive tactics.
Subscribe to:
Post Comments (Atom)
< + > New Smart Data Archiving Features at MediQuant
MediQuant is a data migration and health data archiving company for hospitals, health systems and medical practices. It offers healthcare o...
No comments:
Post a Comment